Related Experiment Video
Updated: May 28, 2025
09:51
Author Spotlight: A Selective Luciferase-Based Assay for Monitoring ATG4B 27 Activity in Cells
Published on: June 30, 2023
747
A cell-based drug screening assay on a centrifugal platform
Chia-Tse Shih1, Huan-Jun Guo1, Chih-Hsin Shih1
1Department of Chemical Engineering, Feng Chia University, No. 100, Wenhua Road, Taichung 407102, Taiwan.
Biofabrication
|February 11, 2025
Summary
This study presents a novel centrifugal microfluidic platform for automated drug screening. The system efficiently generates concentration gradients and automates cell culturing, offering a low-cost and rapid solution for pharmaceutical research.
Area of Science:
- Biotechnology
- Drug Discovery
- Microfluidics
Background:
- Drug screening is crucial in pharmaceutical research for assessing compound effects on cellular behavior.
- Traditional concentration gradient tests for cell cultures are manual, labor-intensive, and time-consuming.
- Microfluidic technology offers improved efficiency, sensitivity, and reduced reagent use in drug screening.
Purpose of the Study:
- To develop an automated, efficient, and low-cost centrifugal microfluidic platform for drug screening.
- To enable rapid generation of concentration gradients for cell-based assays.
- To automate cell culturing processes within a microfluidic system.
Main Methods:
- A centrifugal microfluidic platform was designed with an inner disk for concentration gradient generation and an outer ring for cell culturing.
- The platform utilizes centrifugal force for fluid handling, including pumping, metering, and mixing.
- Automated waste removal and nutrient replenishment were integrated into the cell culturing system.
Main Results:
- The centrifugal platform successfully established concentration gradients for cell growth.
- Automated cell culturing with waste discharge and medium replenishment was demonstrated.
- The system provides a rapid and efficient method for drug screening.
Conclusions:
- The proposed centrifugal microfluidic platform offers an efficient and low-cost solution for drug screening.
- Automation of concentration gradient generation and cell culturing significantly reduces manual labor and time.
- This technology has the potential to accelerate drug development and pharmaceutical research.
